Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-29T10:54:49.319Z Has data issue: false hasContentIssue false

Case 21: - The menopause blues

Published online by Cambridge University Press:  03 April 2024

By
Nevena Radonjić  and
Jaclyn Blaauboer
Edited by
Nevena V. Radonjić ,
Thomas L. Schwartz  and
Stephen M. Stahl
Nevena V. Radonjić
Affiliation:
State University of New York Upstate Medical University
Thomas L. Schwartz
Affiliation:
State University of New York Upstate Medical University
Stephen M. Stahl
Affiliation:
University of California, San Diego
Get access

Summary

What medication(s) has the most evidence in the treatment of both perimenopausal depression and vasomotor symptoms (VMS)?

Keywords

menopausedepressionvasomotor symptomsvenlafaxine ER (Effexor)gabapentin (Neurontin)clonidine (Catapres)
Type
Chapter
Information
Case Studies: Stahl's Essential Psychopharmacology , pp. 363 - 378
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Avis, NE, Brambilla, D, McKinlay, SM, et al. A longitudinal analysis of the association between menopause and depression results from the Massachusetts Women’s Health Study. Ann Epidemiol 1994; 4:214–20CrossRefGoogle ScholarPubMed
Chen, LC, Yang, AC, Su, TP, et al. Symptomatic menopausal transition and subsequent bipolar disorder among midlife women with major depression: a nationwide longitudinal study. Arch Womens Ment Health 2017; 20:463–8Google ScholarPubMed
Cohen, LS, Soares, CN, Joffe, H. Diagnosis and management of mood disorders during the menopausal transition. Am J Med 2005; 118:93–7CrossRefGoogle ScholarPubMed
Davis, SR, Jane, F. Menopause, sex and perimenopause. Aust Fam Physician 2011; 40:274–8Google ScholarPubMed
Freedman, RR. Hot flashes: behavioral treatments, mechanisms, and relation to sleep. Am J Med 2005; 118 Suppl, 12B:124–30CrossRefGoogle ScholarPubMed
Geller, SE, Studee, L. Botanical and dietary supplements for menopausal symptoms: what works, what does not. J Women’s Health (Larchmt) 2005;14:634–49CrossRefGoogle ScholarPubMed
Kingsberg, SA. Hypoactive Sexual Desire Disorder: understanding the impact on midlife women. Female Patient 2011; 36:1–4Google Scholar
Kroon, JS, Wohlfarth, TD, Dieleman, J, et al. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. Bipolar Disord 2013; 15:306–13CrossRefGoogle ScholarPubMed
Lee, JH, Lee, JE, Harsh, V, et al. Pharmacotherapy for sexual dysfunction in women. Curr Psychiatry Rep 2022; 24:99–109CrossRefGoogle ScholarPubMed
Marsh, WK, Templeton, A, Ketter, TA, et al. Increased frequency of depressive episodes during the menopausal transition in women with bipolar disorder: preliminary report. J Psychiatr Res 2008; 42:247–51CrossRefGoogle ScholarPubMed
Pachman, DR, Jones, JM, Loprinzi, CL. Management of menopause-associated vasomotor symptoms: current treatment options, challenges and future directions. Int J Womens Health 2010; 2:123–35Google ScholarPubMed
Parish, SJ, Hahn, SR, Goldstein, SW, et al. The International Society for the Study of Women’s Sexual Health process of care for the identification of sexual concerns and problems in women. Mayo Clin Proc 2019; 94:842–56CrossRefGoogle Scholar
Perich, TA, Roberts, G, Frankland, A, et al. Clinical characteristics of women with reproductive cycle–associated bipolar disorder symptoms. Aust N Z J Psychiatry 2017; 51:161–7CrossRefGoogle ScholarPubMed
Saito, K, Cui, H. Emerging roles of estrogen-related receptors in the brain: potential interactions with estrogen signaling. Int J Mol Sci 2018; 19:1091CrossRefGoogle ScholarPubMed
Stahl, SM, Muntner, N. Depression in Women: Treating Symptoms throughout the Life Span. Cambridge: Cambridge University Press, 2021, 129–42Google Scholar
Stubbs, C, Mattingly, L, Crawford, SA, et al. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women: HHS public access summary of the issues. J Okla State Med Assoc 2017; 110:272–4Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×